Stock Screener App

Gratuito -

Installare

88.37

8.91% -8.64

Pre-mercato: 88.70 0.33 +0.37%

Inhibrx Biosciences Inc (INBX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	0.10	-
Operating Expenses	33.81	-	42.90	50.03	46.80
Operating Income/Loss	-33.81	-	-42.90	-49.93	-46.80
Nonoperating Income/Loss	-1.444	-	-0.41	2.063	2.933
Income/Loss From Continuing Operations Before Tax	23.04% -35.26	-28.65	-43.31	-47.87	-43.86
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	23.04% -35.26	-28.65	-43.31	-47.87	-43.86
Net Income/Loss	23.04% -35.26	-28.65	-43.31	-47.87	-43.86
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	15.48	-	15.47	0.224	15.47
Diluted Average Shares	15.48	-	15.47	0.163	15.47
Basic Earnings Per Share	-2.28	-	-2.80	-5.03	-2.84
Diluted Earnings Per Share	-2.28	-	-2.80	-4.47	-2.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$63.32

0.52%

RPRX

$58.60

0.07%

ROIV

$36.20

0.22%

INSM

$123.74

2.05%

ALNY

$228.65

0.67%

ONC

$347.48

2.40%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters